Skip to Content

Antibodies, Volume 12, Issue 1

2023 March - 25 articles

Cover Story: Matrix metalloproteinase 9 (MMP9), a protease implicated in multiple diseases, is secreted as an inactive zymogen and requires proteolytic removal of the pro-domain for activation. The relative levels and functionality of the pro- and active-MMP9 isoforms in tissues are not characterized. We generated a specific antibody that distinguishes an active form of MMP9, F107-MMP9, from the inactive pro-MMP9 isoform. Using multiple in vitro assays and specimen types, we show that F107-MMP9 expression is localized and disease-specific compared with its more abundant parental pro-form. It is detected around sites of active tissue remodeling, including fistulae of inflammatory bowel and dermal fissures in hidradenitis suppurativa, and is expressed by myeloid cells, including macrophages and neutrophils. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (25)

  • Review
  • Open Access
20 Citations
14,776 Views
19 Pages

21 March 2023

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a group of rare systemic diseases affecting small-caliber vessels. The damage caused by AAV mainly involves the lung and kidneys. AAV includes three different types: granulomatosis...

  • Review
  • Open Access
11 Citations
7,479 Views
13 Pages

16 March 2023

The application of antibodies in cells was first shown in the early 1990s, and subsequently, the field of intracellular antibodies has expanded to encompass antibody fragments and their use in target validation and as engineered molecules that can be...

  • Article
  • Open Access
3,213 Views
25 Pages

Defensin Interactions in Relation to Monoclonal and Disease-Related Proteinase 3 Antibodies Binding at the Catalytic Site

  • Morten Zoega,
  • Nicole Hartwig Trier,
  • Rikke Guldhammer Nejrup,
  • Anna Chailyan,
  • Tina Friis,
  • Peter Højrup and
  • Gunnar Houen

13 March 2023

Proteinase 3 (PR3) is a neutrophil granulocyte enzyme and an autoantigen found in several forms of vasculitis. Due to the diagnostic and clinical importance of antibodies (Abs) to PR3, it is important to characterize the protein and the nature of its...

  • Article
  • Open Access
9 Citations
3,504 Views
9 Pages

10 March 2023

Cytomegalovirus (CMV) infection can cause newborn morbidity and mortality; no pharmacological method of reducing CMV infection during pregnancy is currently available. In a phase 1 study in the United States, V160, a conditionally replication-defecti...

  • Review
  • Open Access
2 Citations
4,596 Views
16 Pages

Cutaneous Lymphoma and Antibody-Directed Therapies

  • Alvise Sernicola,
  • Christian Ciolfi,
  • Paola Miceli and
  • Mauro Alaibac

The introduction of monoclonal antibodies such as rituximab to the treatment of cancer has greatly advanced the treatment scenario in onco-hematology. However, the response to these agents may be limited by insufficient efficacy or resistance. Antibo...

  • Review
  • Open Access
35 Citations
13,388 Views
24 Pages

Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine

  • Tsvetelina Velikova,
  • Metodija Sekulovski,
  • Simona Bogdanova,
  • Georgi Vasilev,
  • Monika Peshevska-Sekulovska,
  • Dimitrina Miteva and
  • Tsvetoslav Georgiev

Intravenous administration of immunoglobulins has been routinely used for more than 60 years in clinical practice, developed initially as replacement therapy in immunodeficiency disorders. Today, the use of intravenous immunoglobulins (IVIGs) is embe...

  • Article
  • Open Access
1 Citations
3,605 Views
13 Pages

Pilot Study Results on Antibodies to the S- and N-Proteins of SARS-CoV-2 in Paired Sera from COVID-19 Patients with Varying Severity

  • Yulia Desheva,
  • Anna Lerner,
  • Tamara Shvedova,
  • Olga Kopteva,
  • Polina Kudar,
  • Irina Koroleva,
  • Galina Leontieva and
  • Alexander Suvorov

27 February 2023

In this retrospective cohort study, we investigated the formation of individual classes of antibodies to SARS-CoV-2 in archived serial sera from hospitalized patients with the medium–severe (n = 17) and severe COVID-19 (n = 11). The serum/plasm...

  • Review
  • Open Access
24 Citations
7,051 Views
14 Pages

Serological Cross-Reactivity in Zoonotic Flaviviral Infections of Medical Importance

  • Priscilla Gomes da Silva,
  • José Augusto Seixas dos Reis,
  • Marcio Nogueira Rodrigues,
  • Quézia da Silva Ardaya and
  • João Rodrigo Mesquita

24 February 2023

Flaviviruses are enveloped RNA viruses from the family Flaviviridae that comprise many important human pathogenic arboviruses such as Yellow Fever, Dengue, and Zika viruses. Because they belong to the same genus, these viruses show sequence and struc...

  • Article
  • Open Access
19 Citations
4,801 Views
21 Pages

23 February 2023

Mutation(s) in the spike protein is the major characteristic trait of newly emerged SARS-CoV-2 variants such as Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), and Delta-plus. Omicron (B.1.1.529) is the latest addition and it has bee...

  • Communication
  • Open Access
2 Citations
3,146 Views
8 Pages

Bioprocess Development and Characterization of a 13C-Labeled Hybrid Bispecific Antibody Produced in Escherichia coli

  • Aaron T. Wecksler,
  • Victor Lundin,
  • Ambrose J. Williams,
  • Karthik Veeravalli,
  • Dorothea E. Reilly and
  • Sung-Hye Grieco

14 February 2023

Monoclonal antibodies (mAbs) are highly efficacious therapeutics; however, due to their large, dynamic nature, structural perturbations and regional modifications are often difficult to study. Moreover, the homodimeric, symmetrical nature of mAbs mak...

  • Review
  • Open Access
20 Citations
8,474 Views
19 Pages

Non-Affinity Purification of Antibodies

  • Tsutomu Arakawa,
  • Yui Tomioka,
  • Masataka Nakagawa,
  • Chiaki Sakuma,
  • Yasunori Kurosawa,
  • Daisuke Ejima,
  • Kouhei Tsumoto and
  • Teruo Akuta

13 February 2023

Currently, purification of antibodies is mainly carried out using a platform technology composed primarily of Protein A chromatography as a capture step, regardless of the scale. However, Protein A chromatography has a number of drawbacks, which are...

  • Article
  • Open Access
2 Citations
4,826 Views
20 Pages

Characterization of an IDH1 R132H Rabbit Monoclonal Antibody, MRQ-67, and Its Applications in the Identification of Diffuse Gliomas

  • Raul Copaciu,
  • Juliet Rashidian,
  • Joshua Lloyd,
  • Aril Yahyabeik,
  • Jennifer McClure,
  • Kelsea Cummings and
  • Qin Su

6 February 2023

The current diagnosis of diffuse glioma involves isocitrate dehydrogenase (IDH) mutation testing. Most IDH mutant gliomas carry a G-to-A mutation at IDH1 position 395, resulting in the R132H mutant. R132H immunohistochemistry (IHC), therefore, is use...

  • Case Report
  • Open Access
6 Citations
4,178 Views
9 Pages

Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and Polymyositis

  • Linda Di Pietro,
  • Fabio Chiccoli,
  • Lorenzo Salvati,
  • Emanuele Vivarelli,
  • Alessandra Vultaggio,
  • Andrea Matucci,
  • Chelsea Bentow,
  • Michael Mahler,
  • Paola Parronchi and
  • Boaz Palterer

3 February 2023

Anti-RuvBL1/2 autoantibodies have recently been detected in patients with systemic sclerosis (SSc) and scleromyositis overlap syndromes. These autoantibodies exhibit a distinct speckled pattern in an indirect immunofluorescent assay on Hep-2 cells. W...

  • Communication
  • Open Access
1 Citations
3,618 Views
9 Pages

31 January 2023

C-C chemokine receptor 9 (CCR9) is a receptor for C-C-chemokine ligand 25 (CCL25). CCR9 is crucial in the chemotaxis of immune cells and inflammatory responses. Moreover, CCR9 is highly expressed in tumors, including several solid tumors and T-cell a...

  • Case Report
  • Open Access
5 Citations
3,465 Views
7 Pages

25 January 2023

Stimulation of the antitumor activity of the immune system using immune checkpoint inhibitors (ICIs) has proven efficacy in the treatment of multiple types of cancer, inducing the speedily expanding approval of therapeutic indications for ICIs. The l...

  • Feature Paper
  • Article
  • Open Access
13 Citations
6,315 Views
13 Pages

Characterization of Active MMP9 in Chronic Inflammatory Diseases Using a Novel Anti-MMP9 Antibody

  • Maile Velasquez,
  • Chris O’Sullivan,
  • Robert Brockett,
  • Amanda Mikels-Vigdal,
  • Igor Mikaelian,
  • Victoria Smith and
  • Andrew E. Greenstein

18 January 2023

Matrix metalloproteinase 9 (MMP9), a protease implicated in multiple diseases, is secreted as an inactive zymogen and requires proteolytic removal of the pro-domain for activation. The relative levels and functionality of the pro- and active-MMP9 iso...

  • Commentary
  • Open Access
6 Citations
4,497 Views
6 Pages

14 January 2023

Driven by necessity, the COVID-19 pandemic caused by SARS-CoV-2 has accelerated the development and implementation of new vaccine platforms and other viral therapeutics. Among these is the therapeutic use of antibodies including single-domain antibod...

  • Review
  • Open Access
23 Citations
7,402 Views
16 Pages

11 January 2023

Monoclonal antibodies are a promising treatment for COVID-19. However, the emergence of SARS-CoV-2 variants raised concerns about these therapies’ efficacy and long-term viability. Studies reported several antibodies, that received authorizatio...

  • Review
  • Open Access
9 Citations
7,276 Views
11 Pages

6 January 2023

The B cell antigen receptor (BCR)-repertoire is capable of recognizing a nearly unlimited number of antigens. Inevitably, the random nature of antibody gene segment rearrangement, needed in order to provide mature B cells, will generate autoreactive...

  • Review
  • Open Access
11 Citations
4,634 Views
13 Pages

Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update

  • Elvis Hysa,
  • Rosanna Campitiello,
  • Silvia Sammorì,
  • Emanuele Gotelli,
  • Andrea Cere,
  • Giampaola Pesce,
  • Carmen Pizzorni,
  • Sabrina Paolino,
  • Alberto Sulli and
  • Maurizio Cutolo
  • + 1 author

4 January 2023

Background: Specific autoantibodies and nailfold videocapillaroscopy (NVC) findings are serum and morphological diagnostic hallmarks of systemic sclerosis (SSc) as well as useful biomarkers which stratify the microvascular progression and prognosis o...

  • Article
  • Open Access
2 Citations
3,234 Views
11 Pages

The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave

  • Atefeh Vaezi,
  • Hamed Fakhim,
  • Saeed Abbasi,
  • Soraya Masoudi,
  • Mahnaz Hosseini Rizi and
  • Shaghayegh Haghjooy Javanmard

23 December 2022

Background: Due to the unclear protective role of produced antibodies and the need for seroepidemiologic studies, we surveyed the COVID-19 seroprevalence among healthcare professionals who had direct or indirect contact with COVID-19 patients. Method...

  • Opinion
  • Open Access
2,729 Views
9 Pages

23 December 2022

(1) Background: philosophical views are important to enable a general and multi-systemic view of the potential understanding of autoimmunity in psychiatric disease that is not solely reflected by an immunological viewpoint. (2) Methods: we reviewed c...

XFacebookLinkedIn
Antibodies - ISSN 2073-4468